Are there criteria for the diagnosis of paraneoplastic fever?;Existe-t-il des criteres diagnostiques en faveur d'une fievre paraneoplasique?

Revue de Medecine Interne

Volumn 21, Issue 8, 2000, Pages 684-692

  Penel, N ^a   Degardin, M ^a   Frippiat, F ^b   Hachulla, E ^c  

^a CENTRE OSCAR LAMBRET   (France)

^b Hospital de Jolimont   (Belgium)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Fever; Naproxen; Paraneoplastic fever

Indexed keywords

DICLOFENAC; INDOMETACIN; INTERLEUKIN 6; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROCALCITONIN; DIAGNOSTIC AGENT;

ADVANCED CANCER; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEVER; HUMAN; HYPERTHERMIA; INFECTION; NEUTROPENIA; PARANEOPLASTIC SYNDROME; REVIEW; PATHOPHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; FEVER; HUMANS; NAPROXEN; PARANEOPLASTIC SYNDROMES;

EID: 0033876433     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)80024-7     Document Type: Article

References (74)

1. The significance of fever in neoplastic disease
2. Fever of unexplained origin: Report of 100 cases
3. Fever in pediatric and young adult patient with cancer. A prospective study of 1001 episodes
4. Clinical studies of fever and infection in cancer
5. Acute infections in cancer patients
6. Infections in the cancer patients: Diagnosis, prevention and treatment
7. Incidence des infections nosocomiales dans un centre anti-cancereux: Donnees cliniques et bacteiologiques
8. The occurrence of fever in malignant disease
9. Liver embolizations of patients with malignant neuro-endocrine gastrointestinal tumors
10. Study of response to naproxen in patients with hepatocellular carcinoma developped fever following transcatheter arterial embolization
11. Fever
12. Tumours and fever
13. Fever: Pathogenesis, pathophysiology and purpose
14. C-reactive protein serum levels is a valuable and simple markers in non-Hogdkin's lymphoma
15. Cytokines level (IL6 anf IFNΥ) acute phase response and nutritionnal status as prognosis in lung cancers
16. Relationship between serum levels of interleukin 6, various parameters, and malnutrition in patients with oesophageal squamous cell carcinoma
17. Interleukin 6 is a survival prognostic factor in renal cell carcinoma
18. IL-6 in a pleomorphic type of a malignant fibrous histiocytoma presenting high fever
19. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma
20. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma
21. Interleukin-6 immunoreactivity in human tumors
22. Impact of weight loss, appetite and the inflammatory response on quality of life in gastro-intestinal cancer patients
23. Cytokines et etats infectieux graves
24. Persistent perplexing pyrexia: Some comments on etiology and diagnosis
25. Fever of undeterminated origin: Diagnosis and follow-up of 105 patients
26. Infectious in the cancer patient
27. Lymphosarcoma: A review of 1269 cases
28. Prognosis in children with tumor metastases prior to or following primary treatment: Results from the First National Wilm's Tumor Study
29. The natural history and clinical features of renal carcinoma
30. Manifestations of metastatic tumors of the liver
31. Cancer du pancreas exocrine
32. Incidence of paramalignant disorders in bronchogenic carcinoma
33. 683 Tumeurs retroperitoneales primitives
34. The effect of naproxene on fever in patients with advanced gynecologic malignancies
35. Tumor fever in patients with nasopharyngeal carcinoma: Clinical experience of 67 patients
36. Chronic lymphocytic leukemia: A new insights into biology and therapy
37. The role of prognostic factors in treatment for early-stage Hodgkin's disease
38. Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma
39. Serum levels of cytokines in patients with untreated primary lung cancer
40. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer
41. Significance of preoperative elevation of C-reactive protein as an indicator for prognosis in colorectal cancer
42. Neoplastic fever, a proposal for diagnosis
43. Problems in distinguishing spinal tuberculosis from neoplasia on MRI
44. Gallium citrate Ga 67 scans in febrile patients
45. 111-Indium-oxine-labeled leukocytes in the diagnosis of localized infection in patients with neoplastic disease
46. Localization of indium-111 leukocytes in non-infected neoplasms
47. The phenomenon of acute phase response
48. Metabolic and scintigraphic studies of radio-iodinated human C-Reactive protein levels in neonatal infectious
49. C-reactive protein is usefull marker for guiding duration of antibiotherapy in suspected neonatal bacterial infection
50. Clinical implications of C-reactive protein in pediatrics
51. High serum concentrations of procalcitonin in patients with sepsis and infection
52. Procalcitonin increase after endotoxin injections in normal subjects
53. A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation
54. CRP levels in autoimmune disease can be specified by measure of procalcitonin
55. Procalcitonin as a marker for the early diagnosis of neonatal infection
56. Serum procalcitonin as an index of inhalation injury in burns
57. Procalcitonin- ein neuer marker der inflammatorischen Wirtsantwart Longitudinal studien bei Patienten mit sepsis und peitonitis
58. Procalcitonin in diagnosis of sever infections
59. Procalcitonin and C-Reactive protein levels in neonatal infectious
60. Serum procalcitonin in melioidis
61. Procalcitonin in patients with and without immunosuppression and sepsis
62. Procalcitonin used as a marker of infection in the intensive care unit
63. Procalcitonin in early detection of postoperative complications
64. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1
65. Antipyretic effect of indomethacin in patients with malignancy
66. Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer
67. Neoplastic fever responds to the treatment of an adequate dose of naproxene
68. The response of paraneoplastic fever of lymphomas and solid tumours to the administration of naproxen
69. The effect of naproxen on fever in children with malignancies
70. A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer induced-fever
71. Antipyretic effect of naproxen and corticosteroids on neoplastic fever
72. The effects of Ibuprofen on the physiology and survival of patients with sepsis
73. Use of naproxen in ameliorating induced paraneoplastic fever
74. Ibuprofen reduces energy exependiture and acute-phase protein production compared with placebo in pancreatic cancer patients